Peroxisome proliferator-activated receptors mediate pleiotropic actions of statins.
Paumelle
Réjane
R
Staels
Bart
B
D000818:Animals; D008078:Cholesterol, LDL / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000235:genetics*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000502:physiology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D047493:PPAR alpha / Q000187:drug effects* / Q000502:physiology; D047495:PPAR gamma / Q000187:drug effects* / Q000502:physiology; D048051:p38 Mitogen-Activated Protein Kinases / Q000502:physiology
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D047493:PPAR alpha; D047495:PPAR gamma; D051546:Cyclooxygenase 2; D048049:Extracellular Signal-Regulated MAP Kinases; D048051:p38 Mitogen-Activated Protein Kinases